Your browser doesn't support javascript.
loading
[Persistent asthma: Chronic therapy quantitative compliance in daily practice]. / Observance du traitement de fond dans l'asthme persistant de l'adulte en pratique courante.
Devillier, P; Ghasarossian, C; Terrioux, P; Schiratti, M; Leutenegger, E.
Afiliação
  • Devillier P; UPRES EA 220, hôpital Foch, département des maladies des voies respiratoires, université Paris-Saclay, 11, rue Guillaume-Lenoir, 92150 Suresnes, France. Electronic address: p.devillier@hopital-foch.org.
  • Ghasarossian C; Département de médecine générale, faculté Paris-Descartes, 75006 Paris, France.
  • Terrioux P; Cabinet médical, 77100 Meaux, France.
  • Schiratti M; Laboratoire TAKEDA France, 92400 Paris-La-Défense, France.
  • Leutenegger E; Direction épidémiologie Gecem, 92120 Montrouge, France.
Rev Mal Respir ; 35(3): 269-278, 2018 Mar.
Article em Fr | MEDLINE | ID: mdl-29609840
ABSTRACT

INTRODUCTION:

The aim of the study was to assess, compliance with maintenance treatment in patients with persistent asthma in clinical practice.

METHODS:

This observational, cross-sectional, prospective, multicenter study was conducted in metropolitan France on patients with persistent asthma under the care of a representative sample of general practitioners and pneumologists. Compliance was determined via access to the Health Insurance database allowing comparison between the actual consumption of medications and the corresponding theoretical consumption related to prescription. Additional compliance data were obtained using the validated Morisky questionnaire.

RESULTS:

Eighty one physicians included 488 patients, mean age of 51 years, 55% women. The statement of consumption (SC) was available for 35% of patients however the Morisky questionnaire (present for 85% of patients) showed a similar compliance between patients with or without SC. The good compliance rate (compliance ≥80%) was observed in 51% based on the SC and in 38% based on the Morisky questionnaire. Among possible predictive factors, only obesity was associated with a bad compliance (19% vs 7%, P<0.05). Patients with poor compliances displayed more severe symptoms and a higher rate of non-control (21.7% vs 5.7%, P<0.01).

CONCLUSIONS:

The statement of consumption is a useful tool to provide quantitative measurement of compliance in daily practice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Cooperação do Paciente / Antiasmáticos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Fr Revista: Rev Mal Respir Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Cooperação do Paciente / Antiasmáticos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Fr Revista: Rev Mal Respir Ano de publicação: 2018 Tipo de documento: Article